Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel Polymer Micelles in Advanced Solid Tumors
NCT05254665Phase 2Unknown
- Sponsor
- Simcere Pharmaceutical Group
- Start
- Feb 2022
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel in solid tumor (advanced stage), esophageal cancer, sponsored by Simcere Pharmaceutical Group. Status: unknown.
02
Drugs
docetaxel
03
Conditions
solid tumor (advanced stage)esophageal cancer
Beyond the preview
Go deeper on NCT05254665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05254665.